{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Hydralazine Hydrochloride is a generic prescription medication used to treat high blood pressure by relaxing blood vessels. It comes as oral tablets in strengths of 10 mg, 25 mg, 50 mg, and 100 mg, manufactured by Ascend Laboratories, LLC under FDA application ANDA200737. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Hydralazine hydrochloride \u2014 ANDA 200737 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200737", "mediaType": "text/html", "title": "Hydralazine hydrochloride"}], "identifier": "ANDA200737", "issued": "2016-09-16", "keyword": ["public-health", "health-care", "prescription-drugs", "drug-safety", "fda"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Hydralazine hydrochloride"}